Literature DB >> 20387008

Comparison of intestinal warm ischemic injury in PACAP knockout and wild-type mice.

Andrea Ferencz1, Peter Kiss, Gyorgy Weber, Zsuzsanna Helyes, Norihito Shintani, Akemichi Baba, Dora Reglodi.   

Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP) is present in the gastrointestinal tract and plays a central role in the intestinal physiology, mainly in the secretion and motility. The aim of our study was to compare the ischemic injury in wild-type and PACAP-38 knockout mice following warm mesenteric small bowel ischemia. Warm ischemia groups were designed with occlusion of superior mesenteric artery for 1, 3, and 6 h in wild-type (n = 10 in each group) and PACAP-38 knockout (n = 10 in each group) mice. Small bowel biopsies were collected after laparotomy (control) and at the end of the ischemia periods. To determine oxidative stress parameters, malondialdehyde (MDA), reduced glutathione (GSH), and superoxide dismutase (SOD) were measured. Tissue damage was analyzed by qualitative and quantitative methods on hematoxylin/eosin-stained sections. In PACAP-38 knockout animals, tissue MDA increased significantly after 3 and 6 h ischemia (133.97 ± 6,2; 141.86 ± 5,8) compared to sham-operated (100.92 ± 3,6) and compared to wild-type results (112.8 ± 2,1; 118.4 ± 1.03 μmol/g, p < 0.05). Meanwhile, tissue concentration of GSH and activity of SOD decreased significantly in knockout mice compared to wild-type form (GSH, 795.97 ± 10.4; 665.1 ± 8,8 vs. 893.23 ± μmol/g; SOD, 94.4 ± 1.4; 81.2 ± 3.9 vs. 208.09 ± 3,7 IU/g). Qualitative and quantitative histological results showed destruction of the mucous, submucous layers, and crypts in knockout mice compared to wild-type tissues. These processes correlated with the warm ischemia periods. Our present results propose an important protective effect of endogenous PACAP-38 against intestinal warm ischemia, which provides basis for further investigation to elucidate the mechanism of this protective effect.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20387008     DOI: 10.1007/s12031-010-9357-6

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  41 in total

1.  The effects of preconditioning on the oxidative stress in small-bowel autotransplantation.

Authors:  Andrea Ferencz; Zalán Szántó; Balázs Borsiczky; Katalin Kiss; Károly Kalmár-Nagy; József Szeberényi; Péter Ors Horváth; Erzsébet Róth
Journal:  Surgery       Date:  2002-11       Impact factor: 3.982

Review 2.  Intestinal ischemia -- the basics.

Authors:  U Haglund; D Bergqvist
Journal:  Langenbecks Arch Surg       Date:  1999-06       Impact factor: 3.445

3.  Pituitary adenylate cyclase activating polypeptide (PACAP) in the gastrointestinal tract of the rat: distribution and effects of capsaicin or denervation.

Authors:  J Hannibal; E Ekblad; H Mulder; F Sundler; J Fahrenkrug
Journal:  Cell Tissue Res       Date:  1998-01       Impact factor: 5.249

4.  PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis.

Authors:  D Vaudry; T F Pamantung; M Basille; C Rousselle; A Fournier; H Vaudry; J C Beauvillain; B J Gonzalez
Journal:  Eur J Neurosci       Date:  2002-05       Impact factor: 3.386

5.  Effects of PACAP on in vitro and in vivo neuronal cell death, platelet aggregation, and production of reactive oxygen radicals.

Authors:  Dóra Reglodi; Zsolt Fábián; Andrea Tamás; Andrea Lubics; József Szeberényi; Tamás Alexy; Kálmán Tóth; Zsolt Márton; Balázs Borsiczky; Erzsébet Rõth; Luca Szalontay; István Lengvári
Journal:  Regul Pept       Date:  2004-12-15

6.  PKA-Bad-14-3-3 and Akt-Bad-14-3-3 signaling pathways are involved in the protective effects of PACAP against ischemia/reperfusion-induced cardiomyocyte apoptosis.

Authors:  B Rácz; B Gasz; F Gallyas; P Kiss; A Tamás; Z Szántó; A Lubics; I Lengvári; G Tóth; O Hegyi; E Roth; D Reglodi
Journal:  Regul Pept       Date:  2007-09-18

Review 7.  Vasoactive intestinal peptide as a healing mediator in Crohn's disease.

Authors:  A Arranz; C Abad; Y Juarranz; J Leceta; C Martinez; R P Gomariz
Journal:  Neuroimmunomodulation       Date:  2008-07-29       Impact factor: 2.492

Review 8.  Tissue glutathione, nutrition, and oxidative stress.

Authors:  T M Bray; C G Taylor
Journal:  Can J Physiol Pharmacol       Date:  1993-09       Impact factor: 2.273

9.  Evaluation of the protective effects of PACAP with cell-specific markers in ischemia-induced retinal degeneration.

Authors:  Tamas Atlasz; Krisztina Szabadfi; Peter Kiss; Andrea Tamas; Gabor Toth; Dora Reglodi; Robert Gabriel
Journal:  Brain Res Bull       Date:  2009-09-12       Impact factor: 4.077

10.  PACAP protects hippocampal neurons against apoptosis: involvement of JNK/SAPK signaling pathway.

Authors:  S Shioda; H Ozawa; K Dohi; H Mizushima; K Matsumoto; S Nakajo; A Takaki; C J Zhou; Y Nakai; A Arimura
Journal:  Ann N Y Acad Sci       Date:  1998-12-11       Impact factor: 5.691

View more
  16 in total

1.  Effects of PACAP on oxidative stress-induced cell death in rat kidney and human hepatocyte cells.

Authors:  Gabriella Horvath; Reka Brubel; Krisztina Kovacs; Dora Reglodi; Balazs Opper; Andrea Ferencz; Peter Szakaly; Eszter Laszlo; Lidia Hau; Peter Kiss; Andrea Tamas; Boglarka Racz
Journal:  J Mol Neurosci       Date:  2010-07-30       Impact factor: 3.444

2.  Comparative examination of inner ear in wild type and pituitary adenylate cyclase activating polypeptide (PACAP)-deficient mice.

Authors:  A Tamas; K Szabadfi; A Nemeth; B Fulop; P Kiss; T Atlasz; R Gabriel; H Hashimoto; A Baba; N Shintani; Zs Helyes; D Reglodi
Journal:  Neurotox Res       Date:  2011-12-28       Impact factor: 3.911

3.  Changes in pituitary adenylate cyclase-activating Peptide 27-like immunoreactive nervous structures in the porcine descending colon during selected pathological processes.

Authors:  Sławomir Gonkowski; Jarosław Całka
Journal:  J Mol Neurosci       Date:  2012-06-17       Impact factor: 3.444

4.  Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivo.

Authors:  K Szabadfi; T Atlasz; P Kiss; B Danyadi; A Tamas; Zs Helyes; H Hashimoto; N Shintani; A Baba; G Toth; R Gabriel; D Reglodi
Journal:  Neurotox Res       Date:  2011-06-30       Impact factor: 3.911

5.  Examination of calcium-binding protein expression in the inner ear of wild-type, heterozygous and homozygous pituitary adenylate cyclase-activating polypeptide (PACAP)-knockout mice in kanamycin-induced ototoxicity.

Authors:  A Nemeth; K Szabadfi; B Fulop; D Reglodi; P Kiss; J Farkas; B Szalontai; R Gabriel; H Hashimoto; A Tamas
Journal:  Neurotox Res       Date:  2013-10-24       Impact factor: 3.911

6.  Changes of PACAP immunoreactivities and cytokine levels after PACAP-38 containing intestinal preservation and autotransplantation.

Authors:  Klara Nedvig; Gyorgy Weber; Jozsef Nemeth; Krisztina Kovacs; Dora Reglodi; Agnes Kemeny; Andrea Ferencz
Journal:  J Mol Neurosci       Date:  2012-08-17       Impact factor: 3.444

7.  Effects of pituitary adenylate cyclase activating polypeptide on human sperm motility.

Authors:  R Brubel; P Kiss; A Vincze; A Varga; A Varnagy; J Bodis; L Mark; E Jambor; G Maasz; H Hashimoto; Zs Helyes; G Toth; A Tamas; M Koppan; D Reglodi
Journal:  J Mol Neurosci       Date:  2012-05-26       Impact factor: 3.444

Review 8.  VIP and PACAP: recent insights into their functions/roles in physiology and disease from molecular and genetic studies.

Authors:  Terry W Moody; Tetsuhide Ito; Nuramy Osefo; Robert T Jensen
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2011-02       Impact factor: 3.243

9.  PACAP is an endogenous protective factor-insights from PACAP-deficient mice.

Authors:  D Reglodi; P Kiss; K Szabadfi; T Atlasz; R Gabriel; G Horvath; P Szakaly; B Sandor; A Lubics; E Laszlo; J Farkas; A Matkovits; R Brubel; H Hashimoto; A Ferencz; A Vincze; Z Helyes; L Welke; A Lakatos; A Tamas
Journal:  J Mol Neurosci       Date:  2012-04-14       Impact factor: 3.444

Review 10.  PACAP deficiency as a model of aging.

Authors:  D Reglodi; T Atlasz; E Szabo; A Jungling; A Tamas; T Juhasz; B D Fulop; A Bardosi
Journal:  Geroscience       Date:  2018-10-22       Impact factor: 7.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.